CERS Q3 2022 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+9.5% YoY

Gross Profit

$22M55.4% margin

Operating Income

-$7M-18.8% margin

Net Income

-$8M-21.4% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-3.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$215M

Total Liabilities

$141M

Stockholders' Equity

$73M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$36M	+9.5%
Gross Profit	$22M	$19M	+18.1%
Operating Income	-$7M	-$11M	+33.1%
Net Income	-$8M	-$12M	+31.8%

Revenue Segments

Product

$22M100%

Geographic Segments

North America

$26M66%

Europe Middle East And Africa

$13M33%

Other

$377,0001%